Boston Scientific Cardiovascular — Goodwill acquired increased by 1333.3% to $37.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 516.7%, from $6.00M to $37.00M. Over 4 years (FY 2021 to FY 2025), Cardiovascular — Goodwill acquired shows an upward trend with a 43.4% CAGR.
Higher values indicate aggressive inorganic expansion and investment in new cardiovascular technologies.
Reflects the value of goodwill added to the Cardiovascular segment balance sheet during the current reporting period due...
Standard acquisition accounting metric found in segment disclosures for acquisitive healthcare firms.
bsx_segment_cardiovascular_goodwill_acquired| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $210.00M | $988.00M | $1.00M | $41.00M | $0.00 | $336.00M | $4.00M | -$2.00M | $0.00 | $0.00 | $46.00M | $563.00M | $6.00M | $205.00M | $648.00M | -$3.00M | $37.00M |
| QoQ Change | — | — | — | +370.5% | -99.9% | >999% | -100.0% | — | -98.8% | -150.0% | +100.0% | — | — | >999% | -98.9% | >999% | +216.1% | -100.5% | >999% |
| YoY Change | — | — | — | — | — | — | -100.0% | -66.0% | +300.0% | -104.9% | — | -100.0% | >999% | >999% | — | — | >999% | -100.5% | +516.7% |